Synopsis:- An ace investor acquired a 1.1% stake by purchasing 1,05,693 shares in an alcohol-focused company during Q3FY26. The business showed strong operational recovery, margin expansion from 2% to 9%, low leverage of 0.13, and healthy fundamentals with a Piotroski...
SYNOPSIS: Several small- and mid-cap stocks are trading in oversold territory, with RSI levels ranging between 16 and 29. Market capitalisations span ₹9,000–₹46,000 crore, while recent prices show sharp corrections, increasing the possibility of a short-term...
Synopsis:- India’s data centre boom is accelerating, with 1–2 GW capacity planned by 2028. Major listed players are committing ₹3,600 crore to ₹98,000 crore and 1 GW-scale projects, driven by AI, cloud adoption, and digitalisation, positioning India as a leading Asian...
Synopsis: Ajanta Pharma, Lloyds Metals, and Emami saw promoter pledges rise in Q3FY26, with pledge levels at 17.29%, 14.42%, and 11.60%, requiring investor monitoring closely now. Promoter pledge refers to the portion of a promoter’s shareholding that is offered as...
Synopsis:- The stock moved up 6% as investors focused on an order book of nearly ₹5,000 crore, about 9× its ₹582 crore market value. Projects are diversified across water (57%), railways (33%), and roads (10%), with presence in 11 states. The shares of the...
Synopsis: The stock moved up 5% after Q3FY26 results, supported by strong operating performance. EBITDA rose 192% year-on-year to ₹71 crore, margins expanded to 35.6%, and a new CEO appointment signaled leadership transition amid a 1.3 GW manufacturing capacity. The...
Synopsis: Shares rose after a Rs 900 crore ($99.2 million) export order from a US firm marked entry into global data centers. The landmark deal, the largest ever, spans 12–20 months and involves supplying hyperscale-grade power transformers, strengthening export...
Synopsis:- Ace investor Mukul Agrawal added fresh stakes in Q3FY26, acquiring 4.4 crore shares (1.68%) in an infrastructure player and 15 lakh shares (1.33%) in a recently listed pharma company. His public portfolio spans 70 stocks with a net worth of ₹6,500+ crore,...
Synopsis:- The NBFC offers 27% upside with a ₹180 target, supported by 27–28% AUM CAGR, improving asset quality, and credit costs of 50–60 bps. A diversified ₹87,975 crore loan book across 23 states, strong solar and wind exposure, and India’s push toward 500 GW...
